急诊内科重症心力衰竭临床分析及诊疗

摘要

目的：对急诊内科重症心力衰竭进行临床分析及对诊疗方法进行探讨。方法以2013年6月～2014年6月我院收治的70例重症心力衰竭患者为研究对象，进行随机分组，分为观察组与对照组各35例，对照组接受常规治疗，观察组在常规治疗的基础上给予美托洛尔和厄贝沙坦氢氯噻嗪治疗。结果观察组心功能Ⅰ级、Ⅱ级患者明显多于对照组，Ⅲ级、Ⅳ级患者明显少于对照组，P 均<0.05；观察组患者治疗后显效率及总有效率显著高于对照组（P<0.05），临床疗效明显优于对照组。结论在常规治疗的基础上给予美托洛尔和厄贝沙坦氢氯噻嗪治疗，可明显提高患者的心功能，缓解患者的心衰症状，疗效显著，值得推广。%Objective Severe heart failure for emergency medicine and clinical analysis methods for diagnosis and treatment are discussed. Methods In June 2013 ~ 2014 June 70 cases admitted to our hospital with severe heart failure patients for the study,were randomly divided into observation group and control group of 35 patients in the control group received conventional treatment,observation group given metoprolol and hydrochlorothiazide irbesartan treatment on the basis of conventional therapy. Results The cardiac function grade Ⅰ,Ⅱ grade were significantly more than the control group, Ⅲ grade, Ⅳ grade were significantly less than the control group,P<0.05; post-treatment observation group were significantly efficiency and total efficiency was significantly higher than the control group (P<0.05),the clinical efficacy was significantly better than the controlgroup. Conclusion Given on the basis of conventional therapy with metoprolol and hydrochlorothiazide irbesartan treatment can significantly improve cardiac function in patients,relieve the symptoms of heart failure,a significant effect,worthy of promotion .